A recent study which used the RPA analysis on ascites samples and pleural effusions obtained from ovarian cancer patients showed significantly higher expression of AKT, cAMP-responsive element binding protein (CREB), and Jun-N-terminal kinase (JNK) in malignant ascites compared to benign effusions (124). The gene discussed is AKT1; the disease is ovarian carcinoma.